These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
AI predicts and Medicare pays; a new model could change everyday healthcareMedicare has introduced a new payment model that could make it easier for AI tools to become part of everyday healthcare. By paying for car...
Mother's Day Special: How AI, apps are empowering women to manage finances, improve health, build careerWomen are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...
War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
Stocks in news: Torrent Power, GAIL, J&K Bank, Ola Electric, Vedanta, InfosysMarkets ended higher for the third consecutive session amidst volatility. Today's trade will focus on ceasefire developments and the MPC me...
Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
AIIMS unveils MadhuNETrAI, India’s first fully validated AI app to detect diabetic retinopathyAIIMS, in collaboration with the Union health ministry and Wadhwani AI, has launched MadhuNETrAI, an AI-powered mobile app for early detect...
Roche to use AI to help diabetics sleep peacefullySwiss pharmaceutical giant Roche announced on Tuesday that it will soon start marketing a new device designed to use artificial intelligenc...
BeatO appoints Amit Gupta as chief product officerGupta has held key leadership positions in leading global organisations and has a proven track record of driving product strategy and techn...
3 ways AI can help you stay on track when it comes to managing diabetesAI can now help you monitor diabetes progression easily.
Want an easy way to manage blood sugar levels in diabetics? Leave it to AIAfter 'insulin in a pill', new tech may help diabetics monitor their blood sugar without painful finger pricks every day.
- FDA approves marketing of first AI device to detect diabetic eye disease
Washington, April 12 (IANS) The US Food and Drug Administration (FDA) permitted on Wednesday the marketing of the first medical device to u...